To explore the relationship between individual KRAS mutants and 249C sensitivity in vivo, we used a colon cancer (SW48) xenograft model with a set of colon cancer cell lines that differ in KRAS mutation status but are otherwise genetically matched. The gene discussed is KRAS; the disease is colonic neoplasm.